Net Cash Provided by (Used in) Operating Activities |
84.9K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
73.6K |
USD |
-13.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-158K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
4.33M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
421 |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
19.2K |
USD |
+5304% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
98.2K |
USD |
+57.3% |
Q3 2024 |
Q3 2024 |
Operating Lease, Liability |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Depreciation |
561 |
USD |
|
Q2 2022 |
Q2 2022 |
Operating Lease, Liability, Current |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
98.2K |
USD |
|
Q3 2024 |
Q3 2024 |
Current Income Tax Expense (Benefit) |
36.5K |
USD |
|
Q1 2022 |
Q1 2022 |
Additional Paid in Capital |
169K |
USD |
+441% |
Q3 2024 |
Q3 2024 |
Current Federal Tax Expense (Benefit) |
480K |
USD |
+193% |
Q1 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
36.2K |
USD |
+418% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
Q3 2024 |